相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liquid biopsy of HPV DNA in cervical cancer
Tak Hong Cheung et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer
Po-Hsuan Su et al.
SCIENTIFIC REPORTS (2019)
Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition
Salvatore Giovanni Vitale et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
Lydia Giannopoulou et al.
TRANSLATIONAL RESEARCH (2019)
The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening
Chao Fang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression
Lei Chang et al.
THERANOSTICS (2019)
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
Julie L. Hentze et al.
MOLECULAR AND CLINICAL ONCOLOGY (2019)
The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues
Nong Yang et al.
BMC CANCER (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
Lydia Giannopoulou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis
M. S. Schuurman et al.
GYNECOLOGIC ONCOLOGY (2018)
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Lydia Giannopoulou et al.
GYNECOLOGIC ONCOLOGY (2018)
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
Chanhee Han et al.
GYNECOLOGIC ONCOLOGY (2018)
Defining Driver DNA Methylation Changes in Human Cancer
Gerd P. Pfeifer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
Lorena Losi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Screening for Ovarian Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Lena Gorgannezhad et al.
LAB ON A CHIP (2018)
Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers
Omer M. Toor et al.
MOLECULAR CANCER THERAPEUTICS (2018)
EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer
Yanisa Rattanapan et al.
CANCER GENETICS (2018)
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
Laura Muinelo-Romay et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
Qiaomei Guo et al.
MOLECULAR CANCER (2018)
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
Han-Wei Lin et al.
EPIGENOMICS (2018)
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
Joshua Moss et al.
NATURE COMMUNICATIONS (2018)
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
Wenna Guo et al.
CLINICAL EPIGENETICS (2018)
CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment
Wenyi Luo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions
Thomas R. Pisanic et al.
CLINICAL CANCER RESEARCH (2018)
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer
James M. Flanagan et al.
CLINICAL CANCER RESEARCH (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Riikka J. Lund et al.
SCIENTIFIC REPORTS (2017)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter et al.
GENOME MEDICINE (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Sarah B. Ng et al.
SCIENTIFIC REPORTS (2017)
Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?
Gaetano Valenti et al.
UPDATES IN SURGERY (2017)
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer
Yan Lu et al.
BIOLOGICAL PROCEDURES ONLINE (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Global trends and predictions in ovarian cancer mortality
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2016)
The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
Ivo Meinhold-Heerlein et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Kristina Warton et al.
ENDOCRINE-RELATED CANCER (2016)
CDH1 germline mutations and hereditary lobular breast cancer
Giovanni Corso et al.
FAMILIAL CANCER (2016)
The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis
Qiang Wang et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Lasse Sommer Kristensen et al.
CLINICAL EPIGENETICS (2016)
Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis
Quan Zhou et al.
PLOS ONE (2016)
Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies
Xiyue Xiao et al.
PLOS ONE (2016)
Cell-free circulating tumor DNA in cancer
Zhen Qin et al.
CHINESE JOURNAL OF CANCER (2016)
Methylation analyses in liquid biopsy
Delphine Lissa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Increase of Incidence and Mortality of Ovarian Cancer during 2003-2012 in Jiangsu Province, China
Zhimei Teng et al.
FRONTIERS IN PUBLIC HEALTH (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Clinical utility of RASSF1A methylation in human malignancies
A. M. Grawenda et al.
BRITISH JOURNAL OF CANCER (2015)
Quantitative analysis of cell-free DNA in ovarian cancer
Xuefeng Shao et al.
ONCOLOGY LETTERS (2015)
The RASSF1A Tumor Suppressor Regulates XPA-Mediated DNA Repair
Howard Donninger et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
I. Balgkouranidou et al.
BRITISH JOURNAL OF CANCER (2014)
Advances in tumor markers of ovarian cancer for early diagnosis
X. Dong et al.
INDIAN JOURNAL OF CANCER (2014)
PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening
Yuen-Yee Kan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)
Ourania Koukoura et al.
MOLECULAR MEDICINE REPORTS (2014)
Clinical importance and therapeutic implication of E-cadherin gene methylation in human ovarian cancer
Xiao Wu et al.
MEDICAL ONCOLOGY (2014)
Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer
Qiufeng Qi et al.
BIOMEDICAL REPORTS (2014)
Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients
J. M. Flanagan et al.
ANNALS OF ONCOLOGY (2013)
A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA
Qing Zhang et al.
GYNECOLOGIC ONCOLOGY (2013)
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
Aleksandra Majchrzak-Celinska et al.
JOURNAL OF APPLIED GENETICS (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
PAX Genes in Cancer; Friends or Foes?
Caiyun G. Li et al.
Frontiers in Genetics (2012)
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
Thomas E. Liggett et al.
GYNECOLOGIC ONCOLOGY (2011)
Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease
Pauline Wimberger et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
Aparna A. Kamat et al.
CANCER (2010)
Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity
Su Jung Song et al.
CANCER RESEARCH (2009)
An epigenetic marker panel for screening and prognostic prediction of ovarian cancer
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
Andrew E. Teschendorff et al.
PLOS ONE (2009)
PTEN: a new guardian of the genome
Y. Yin et al.
ONCOGENE (2008)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
Qinghua Wu et al.
MOLECULAR CANCER (2007)
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
Louise van der Weyden et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data
Hui-Juan Yang et al.
BMC CANCER (2006)
Worldwide burden of gynaecological cancer: The size of the problem
R Sankaranarayanan et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2006)
A PANorama of PAX genes in cancer and development
EJD Robson et al.
NATURE REVIEWS CANCER (2006)
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
F Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Hypermethylation of the PTEN gene in ovarian cancer cell lines
T Schönorf et al.
CANCER LETTERS (2004)
Expression of BRCA I protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA I gene
C Wang et al.
JOURNAL OF PATHOLOGY (2004)
The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation
L Shivakumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
A Agathanggelou et al.
ONCOGENE (2001)
分享论文
